EMPAA L 5/25MG TAB

EMPAA L 5/25MG is a combination tablet containing Empagliflozin 5mg and Linagliptin 25mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion in response to rising blood sugar levels. Suitable for patients requiring combination therapy to achieve optimal glycemic control. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.